Live Long-Distance TeleRobotic Procedures to Highlight Stereotaxis Technology at Asia Pacific Heart Rhythm Symposium
August 16, 2023 08:40 ET
|
Stereotaxis, Inc.
ST. LOUIS, Aug. 16, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that its...
Stereotaxis Reports 2023 Second Quarter Financial Results
August 10, 2023 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial...
Stereotaxis and Abbott Combine Technologies in First Integrated Procedures to Treat Arrhythmia Patients
July 18, 2023 09:18 ET
|
Stereotaxis, Inc.
ST. LOUIS, July 18, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the first...
Stereotaxis to Report Second Quarter 2023 Financial Results on August 10, 2023
July 17, 2023 06:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, July 17, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will...
Stereotaxis to Initiate First-in-Human Trial to Support CE Mark Application of MAGiC Catheter
June 15, 2023 16:10 ET
|
Stereotaxis, Inc.
ST. LOUIS, June 15, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it...
Stereotaxis to Participate in 20th Annual Craig-Hallum Institutional Investor Conference
May 25, 2023 08:56 ET
|
Stereotaxis, Inc.
ST. LOUIS, May 25, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David...
Advocate Christ Medical Center Extends Leadership in Heart Care with Adoption of Genesis Robotic Technology
May 23, 2023 08:46 ET
|
Stereotaxis, Inc.
ST. LOUIS, May 23, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in robotic technologies for the treatment of cardiac arrhythmias, today announced the first treatment of...
Stereotaxis and Abbott Announce Global Collaboration Combining Leading Mapping and Robotic Technologies to Improve Treatment of Abnormal Heart Rhythms
May 19, 2023 08:38 ET
|
Stereotaxis, Inc.
ST. LOUIS, May 19, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) today announced a global collaboration with Abbott (NYSE: ABT) to integrate Abbott’s EnSite™ X EP System with Stereotaxis’...
Stereotaxis Reports 2023 First Quarter Financial Results
May 09, 2023 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, May 09, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial...
Stereotaxis to Report First Quarter 2023 Financial Results on May 9, 2023
April 18, 2023 09:05 ET
|
Stereotaxis, Inc.
ST. LOUIS, April 18, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it...